SEC Form 4 · accession 0001365916-17-000064
AMYRIS, INC. · AMRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Aug 2, 2017
Accepted (ET)
Aug 4, 2017 · 7:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365916
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 2, 2017 | A | 1,133 | $0.00 | A | 3,066 | D | |
| Common StockF2,F3 | holding | — | — | — | 498,974 | I | by Biolding Investment SA |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $3.93 | Aug 2, 2017 | A | 1,733 | A | — | Aug 2, 2027 | Common Stock | 1,733 | 1,733 | D |
Explanation of responses
- F1Represents a restricted stock unit award that vests as to 100% of the units subject to the award on August 2, 2018.
- F2Reflects a 1-for-15 reverse stock split which became effective on June 5, 2017.
- F3The Reporting Person is a director of Biolding Investment SA ("Biolding") and indirectly holds a majority of Biolding's outstanding shares, and, as such, may be deemed to share voting and investment power over the securities held by Biolding. The Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
- F4Stock option vests as to 100% of the total number of shares subject to the option on August 2, 2018.